ReviewHeliyon2024

Programmed death receptor-1/programmed death-ligand 1 inhibitors: Clinical progress and biomarker exploration in gastric cancer.

Jin Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.